Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14. | Elife | 2022 | 35881547 | PubTator, text mining | PubMed |
| Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. | J Clin Invest | 2022 | 35881486 | PubTator, text mining | PubMed |
| HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma. | J Oncol | 2022 | 35865089 | PubTator, text mining | PubMed |
| Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis. | Front Genet | 2022 | 35865015 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma. | Front Genet | 2022 | 35860473 | PubTator, text mining | PubMed |
| Class I PI3K regulatory subunits control differentiation of dendritic cell subsets and regulate Flt3L mediated signal transduction. | Sci Rep | 2022 | 35853935 | PubTator, text mining | PubMed |
| The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer. | Front Genet | 2022 | 35846130 | PubTator, text mining | PubMed |
| Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner. | Front Immunol | 2022 | 35844577 | PubTator, text mining | PubMed |
| The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. | Nat Commun | 2022 | 35840578 | PubTator, text mining | PubMed |
| Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition. | Br J Haematol | 2022 | 35837798 | PubTator, text mining | PubMed |
| Insights into intercellular receptor-ligand binding kinetics in cell communication. | Front Bioeng Biotechnol | 2022 | 35837553 | PubTator, text mining | PubMed |
| A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma. | Biol Proced Online | 2022 | 35836132 | PubTator, text mining | PubMed |
| Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas. | Front Genet | 2022 | 35832194 | PubTator, text mining | PubMed |
| Recent advances in "sickle and niche" research - Tribute to Dr. Paul S Frenette. | Stem Cell Reports | 2022 | 35830837 | PubTator, text mining | PubMed |
| Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. | J Big Data | 2022 | 35818395 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and immune infiltration characteristics in severe asthma. | Int J Immunopathol Pharmacol | 2022 | 35817495 | PubTator, text mining | PubMed |
| A comparison of conventional and advanced electroanalytical methods to detect SARS-CoV-2 virus: A concise review. | Chemosphere | 2022 | 35817176 | PubTator, text mining | PubMed |
| Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm. | Front Oncol | 2022 | 35814431 | PubTator, text mining | PubMed |
| A Novel Matrisomal-Related LncRNA Signature Associated With Survival Outcome and Immune Evasion in Patients With Gastric Cancer. | Front Oncol | 2022 | 35814410 | PubTator, text mining | PubMed |
| The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma. | Front Genet | 2022 | 35812752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=43